Safety of a new post-operative wound care dressing.
Phase 1
- Conditions
- Seborrheic keratosis, Arochordon, Epidermal nevus, Vulgar wart, Senile pigmented spotsFacial benign small tumors
- Registration Number
- JPRN-jRCTs032190153
- Lead Sponsor
- Hasegawa Toshio
- Brief Summary
There was no safety problem by covering the wound surface of the CO2 laser treatment site with the wound dressing (FF).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Outpatients who will receive the CO2 laser cauterization treatment of facial benign small tumors
Exclusion Criteria
Patients with chronic inflammatory skin diseases (atopic dermatitis, psoriasis, pruritus, etc.)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Delayed epithelialization, 2. Secondary infections, 3. Scar formation
- Secondary Outcome Measures
Name Time Method